Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment
Clinical trial NCT05328167 · COMPLETED
Trial details
- NCT number
- NCT05328167
- Sponsor
- Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2025-07-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.